Annual SGA
$13.86 M
+$1.28 M+10.17%
December 31, 2023
Summary
- As of February 8, 2025, SLS annual SGA is $13.86 million, with the most recent change of +$1.28 million (+10.17%) on December 31, 2023.
- During the last 3 years, SLS annual SGA has risen by +$4.26 million (+44.40%).
- SLS annual SGA is now -14.57% below its all-time high of $16.23 million, reached on December 31, 2014.
Performance
SLS SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$2.97 M
+$532.00 K+21.85%
September 30, 2024
Summary
- As of February 8, 2025, SLS quarterly SGA is $2.97 million, with the most recent change of +$532.00 thousand (+21.85%) on September 30, 2024.
- Over the past year, SLS quarterly SGA has dropped by -$113.00 thousand (-3.67%).
- SLS quarterly SGA is now -69.09% below its all-time high of $9.60 million, reached on June 30, 2014.
Performance
SLS Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$919.72 M
-$32.28 M-3.64%
September 30, 2024
Summary
- As of February 8, 2025, SLS TTM SGA is -$919.72 million, with the most recent change of -$32.28 million (-3.64%) on September 30, 2024.
- Over the past year, SLS TTM SGA has dropped by -$933.58 million (-6734.84%).
Performance
SLS TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
SLS Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10.2% | -3.7% | -6734.8% |
| 3 y3 years | +44.4% | -5.1% | -6814.3% |
| 5 y5 years | +8.5% | -5.1% | -6814.3% |
SLS Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +22.5% | -34.6% | +21.9% | -78.3% | at low |
| 5 y | 5-year | at high | +44.4% | -34.6% | +49.3% | -148.0% | at low |
| alltime | all time | -14.6% | +2089.9% | -69.1% | +160.6% | <-9999.0% | +20.9% |
SELLAS Life Sciences Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $2.97 M(+21.8%) | $13.02 M(-4.3%) |
| Jun 2024 | - | $2.44 M(-46.3%) | $13.60 M(-4.8%) |
| Mar 2024 | - | $4.53 M(+47.2%) | $14.29 M(+3.1%) |
| Dec 2023 | $13.86 M(+10.2%) | $3.08 M(-13.2%) | $13.86 M(-3.6%) |
| Sep 2023 | - | $3.55 M(+13.5%) | $14.38 M(+5.0%) |
| Jun 2023 | - | $3.13 M(-23.9%) | $13.70 M(+0.2%) |
| Mar 2023 | - | $4.11 M(+14.1%) | $13.66 M(+8.6%) |
| Dec 2022 | $12.58 M(+11.1%) | $3.60 M(+25.7%) | $12.58 M(+9.3%) |
| Sep 2022 | - | $2.86 M(-7.4%) | $11.51 M(+3.9%) |
| Jun 2022 | - | $3.09 M(+2.3%) | $11.08 M(+2.8%) |
| Mar 2022 | - | $3.02 M(+19.7%) | $10.78 M(-4.7%) |
| Dec 2021 | $11.32 M(+17.9%) | $2.53 M(+3.7%) | $11.32 M(-6.3%) |
| Sep 2021 | - | $2.44 M(-12.9%) | $12.08 M(+2.6%) |
| Jun 2021 | - | $2.80 M(-21.5%) | $11.77 M(+7.4%) |
| Mar 2021 | - | $3.56 M(+8.3%) | $10.96 M(+14.2%) |
| Dec 2020 | $9.60 M(-3.3%) | $3.29 M(+54.7%) | $9.60 M(+10.2%) |
| Sep 2020 | - | $2.13 M(+6.9%) | $8.71 M(-2.9%) |
| Jun 2020 | - | $1.99 M(-9.7%) | $8.97 M(-6.8%) |
| Mar 2020 | - | $2.20 M(-8.3%) | $9.62 M(-3.0%) |
| Dec 2019 | $9.92 M(-22.3%) | $2.40 M(+0.6%) | $9.92 M(-2.4%) |
| Sep 2019 | - | $2.38 M(-9.6%) | $10.16 M(+11.4%) |
| Jun 2019 | - | $2.64 M(+5.5%) | $9.12 M(-19.9%) |
| Mar 2019 | - | $2.50 M(-5.4%) | $11.39 M(-10.8%) |
| Dec 2018 | $12.77 M(-15.4%) | $2.64 M(+97.0%) | $12.77 M(-20.7%) |
| Sep 2018 | - | $1.34 M(-72.7%) | $16.11 M(-11.9%) |
| Jun 2018 | - | $4.91 M(+26.5%) | $18.29 M(+6.2%) |
| Mar 2018 | - | $3.88 M(-35.2%) | $17.22 M(+10.2%) |
| Dec 2017 | $15.09 M(+228.5%) | $5.99 M(+70.5%) | $15.62 M(+229.5%) |
| Sep 2017 | - | $3.51 M(-8.6%) | $4.74 M(+16.3%) |
| Jun 2017 | - | $3.84 M(+67.9%) | $4.08 M(+21.6%) |
| Mar 2017 | - | $2.29 M(-146.7%) | $3.35 M(-27.0%) |
| Dec 2016 | $4.59 M(-56.7%) | -$4.90 M(-271.9%) | $4.59 M(-62.4%) |
| Sep 2016 | - | $2.85 M(-8.6%) | $12.23 M(-0.4%) |
| Jun 2016 | - | $3.12 M(-11.6%) | $12.28 M(+11.1%) |
| Mar 2016 | - | $3.52 M(+28.6%) | $11.05 M(+4.1%) |
| Dec 2015 | $10.61 M | $2.74 M(-5.4%) | $10.61 M(-6.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2015 | - | $2.90 M(+53.5%) | $11.35 M(-5.4%) |
| Jun 2015 | - | $1.89 M(-38.9%) | $12.00 M(-39.1%) |
| Mar 2015 | - | $3.09 M(-11.3%) | $19.71 M(-16.0%) |
| Dec 2014 | $16.23 M(+101.2%) | $3.48 M(-1.7%) | $23.45 M(+19.2%) |
| Sep 2014 | - | $3.54 M(-63.1%) | $19.67 M(-2.9%) |
| Jun 2014 | - | $9.60 M(+40.6%) | $20.25 M(+51.6%) |
| Mar 2014 | - | $6.83 M(-2346.7%) | $13.37 M(+65.7%) |
| Dec 2013 | $8.06 M(+22.5%) | -$304.00 K(-107.4%) | $8.06 M(-18.4%) |
| Sep 2013 | - | $4.13 M(+52.4%) | $9.89 M(+38.9%) |
| Jun 2013 | - | $2.71 M(+77.1%) | $7.12 M(+11.7%) |
| Mar 2013 | - | $1.53 M(+0.9%) | $6.37 M(-3.3%) |
| Dec 2012 | $6.58 M(-23.7%) | $1.52 M(+11.6%) | $6.58 M(+0.3%) |
| Sep 2012 | - | $1.36 M(-30.8%) | $6.57 M(-9.7%) |
| Jun 2012 | - | $1.96 M(+12.4%) | $7.28 M(+0.2%) |
| Mar 2012 | - | $1.75 M(+16.5%) | $7.26 M(-15.9%) |
| Dec 2011 | $8.63 M(-1.3%) | $1.50 M(-27.5%) | $8.63 M(-5.0%) |
| Sep 2011 | - | $2.07 M(+6.1%) | $9.09 M(+3.2%) |
| Jun 2011 | - | $1.95 M(-37.5%) | $8.80 M(-5.8%) |
| Mar 2011 | - | $3.12 M(+60.0%) | $9.34 M(+6.7%) |
| Dec 2010 | $8.75 M(+1.4%) | $1.95 M(+9.3%) | $8.75 M(+0.2%) |
| Sep 2010 | - | $1.78 M(-28.4%) | $8.74 M(-1.2%) |
| Jun 2010 | - | $2.49 M(-1.6%) | $8.84 M(-8.0%) |
| Mar 2010 | - | $2.53 M(+30.9%) | $9.61 M(-2.3%) |
| Dec 2009 | $8.63 M(+15.1%) | $1.93 M(+2.2%) | $9.84 M(+1.0%) |
| Sep 2009 | - | $1.89 M(-42.0%) | $9.74 M(-4.5%) |
| Jun 2009 | - | $3.26 M(+18.3%) | $10.19 M(+19.7%) |
| Mar 2009 | - | $2.75 M(+50.3%) | $8.52 M(+15.3%) |
| Dec 2008 | $7.50 M(+59.9%) | $1.83 M(-21.9%) | $7.39 M(+6.2%) |
| Sep 2008 | - | $2.35 M(+48.6%) | $6.95 M(+21.9%) |
| Jun 2008 | - | $1.58 M(-2.8%) | $5.70 M(+8.7%) |
| Mar 2008 | - | $1.63 M(+16.1%) | $5.24 M(+24.6%) |
| Dec 2007 | $4.69 M(+641.1%) | $1.40 M(+27.6%) | $4.21 M(+33.7%) |
| Sep 2007 | - | $1.10 M(-2.2%) | $3.15 M(+53.5%) |
| Jun 2007 | - | $1.12 M(+90.8%) | $2.05 M(+120.9%) |
| Mar 2007 | - | $588.00 K(+72.9%) | $928.00 K(+172.9%) |
| Dec 2006 | $633.00 K | $340.00 K | $340.00 K |
FAQ
- What is SELLAS Life Sciences annual SGA?
- What is the all time high annual SGA for SELLAS Life Sciences?
- What is SELLAS Life Sciences annual SGA year-on-year change?
- What is SELLAS Life Sciences quarterly SGA?
- What is the all time high quarterly SGA for SELLAS Life Sciences?
- What is SELLAS Life Sciences quarterly SGA year-on-year change?
- What is SELLAS Life Sciences TTM SGA?
- What is the all time high TTM SGA for SELLAS Life Sciences?
- What is SELLAS Life Sciences TTM SGA year-on-year change?
What is SELLAS Life Sciences annual SGA?
The current annual SGA of SLS is $13.86 M
What is the all time high annual SGA for SELLAS Life Sciences?
SELLAS Life Sciences all-time high annual SGA is $16.23 M
What is SELLAS Life Sciences annual SGA year-on-year change?
Over the past year, SLS annual SGA has changed by +$1.28 M (+10.17%)
What is SELLAS Life Sciences quarterly SGA?
The current quarterly SGA of SLS is $2.97 M
What is the all time high quarterly SGA for SELLAS Life Sciences?
SELLAS Life Sciences all-time high quarterly SGA is $9.60 M
What is SELLAS Life Sciences quarterly SGA year-on-year change?
Over the past year, SLS quarterly SGA has changed by -$113.00 K (-3.67%)
What is SELLAS Life Sciences TTM SGA?
The current TTM SGA of SLS is -$919.72 M
What is the all time high TTM SGA for SELLAS Life Sciences?
SELLAS Life Sciences all-time high TTM SGA is $0.00
What is SELLAS Life Sciences TTM SGA year-on-year change?
Over the past year, SLS TTM SGA has changed by -$933.58 M (-6734.84%)